David Sholehvar is President, Clinical Services of NEOGENOMICS INC. Currently has a direct ownership of 43,216 shares of NEO, which is worth approximately $599,405. The most recent transaction as insider was on Aug 01, 2022, when has been sold 12,352 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 43.2K
0% 3M change
0% 12M change
Total Value Held $599,405

David Sholehvar Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 01 2022
BUY
Grant, award, or other acquisition
-
12,352 Added 22.23%
43,216 Common Stock
Apr 01 2022
BUY
Grant, award, or other acquisition
-
30,864 Added 50.0%
30,864 Common Stock

Also insider at

NVTA
Invitae Corp Healthcare
DS

David Sholehvar

President, Clinical Services
Fort Myers, FL

Track Institutional and Insider Activities on NEO

Follow NEOGENOMICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NEO shares.

Notify only if

Insider Trading

Get notified when an Neogenomics Inc insider buys or sells NEO shares.

Notify only if

News

Receive news related to NEOGENOMICS INC

Track Activities on NEO